Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
13809 studies found for:    Open Studies | "Neoplasms"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Neoplasms"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Irreversible Electroporation(IRE) For Unresectable Head and Neck Neoplasms
Condition: Head and Neck Neoplasms
Interventions: Procedure: Irreversible electroporation (IRE);   Device: NanoKnife
2 Recruiting Irreversible Electroporation(IRE) For Unresectable Prostatic Neoplasms
Condition: Prostatic Neoplasms
Interventions: Procedure: Irreversible electroporation (IRE);   Device: NanoKnife
3 Recruiting Irreversible Electroporation(IRE) For Unresectable Stomach Neoplasms
Condition: Stomach Neoplasms
Interventions: Procedure: Irreversible electroporation (IRE);   Device: NanoKnife
4 Recruiting Irreversible Electroporation(IRE) For Unresectable Rectal Neoplasms
Condition: Rectal Neoplasms
Interventions: Procedure: Irreversible electroporation (IRE);   Device: NanoKnife
5 Recruiting Irreversible Electroporation(IRE) For Unresectable Hilus Pulmonis Neoplasms
Condition: Hilus Pulmonary Neoplasms
Interventions: Procedure: Irreversible electroporation (IRE);   Device: NanoKnife
6 Recruiting Irreversible Electroporation(IRE) For Unresectable Gallbladder Neoplasms
Condition: Gallbladder Neoplasms
Interventions: Procedure: Irreversible electroporation (IRE);   Device: NanoKnife
7 Recruiting Irreversible Electroporation(IRE) For Unresectable Urinary Bladder Neoplasms
Condition: Urinary Bladder Neoplasms
Interventions: Procedure: Irreversible electroporation (IRE);   Device: NanoKnife
8 Recruiting Irreversible Electroporation(IRE) For Unresectable Laryngeal Neoplasms
Condition: Laryngeal Neoplasms
Interventions: Procedure: Irreversible electroporation (IRE);   Device: NanoKnife
9 Recruiting Irreversible Electroporation(IRE) For Unresectable Esophageal Neoplasms
Condition: Esophageal Neoplasms
Interventions: Procedure: Irreversible electroporation (IRE);   Device: NanoKnife
10 Recruiting Irreversible Electroporation(IRE) For Uterine Cervical Neoplasms
Condition: Uterine Cervical Neoplasms
Interventions: Procedure: Irreversible electroporation (IRE);   Device: NanoKnife
11 Recruiting Irreversible Electroporation(IRE) For Unresectable Renal Pelvic and Ureteral Neoplasms
Condition: Renal Pelvic and Ureteral Neoplasms
Interventions: Procedure: rreversible electroporation (IRE);   Device: NanoKnife
12 Recruiting Malignant Genito-urinary Tumors in Children: South Egypt Cancer Institute Experience
Conditions: Genitourinary Neoplasms;   Neoplasms, Genitourinary
Intervention:
13 Recruiting Family and Personal History of Malignancy in Intraductal Papillary Mucinous Neoplasm (IPMN)
Conditions: Pancreatic Cancer;   Neoplasm
Intervention:
14 Recruiting Irreversible Electroporation(IRE) For Lung Neoplasms Accompanied by Respiratory Function Insufficiency
Condition: Lung Neoplasms Accompanied by Respiratory Function Insufficiency
Interventions: Procedure: Irreversible electroporation (IRE);   Device: NanoKnife
15 Not yet recruiting Embryonal Tumors of Infancy & Childhood: South Egypt Cancer Institute Experience
Conditions: Neoplasms, Embryonal;   Embryonal Neoplasms
Intervention:
16 Recruiting Malignant Pediatric Pelvic Tumors: A Retrospective Study
Conditions: Abdominal Neoplasms;   Pelvic Neoplasms
Intervention:
17 Recruiting A Study of Prexasertib (LY2606368) With Chemotherapy and Radiation in Participants With Head and Neck Cancer
Condition: Head and Neck Neoplasms
Interventions: Drug: Prexasertib;   Drug: Cisplatin;   Drug: Cetuximab;   Radiation: Intensity Modulated Radiation Therapy
18 Recruiting Lifestyle Intervention for Prevention of Gastric Neoplasm
Condition: Stomach Neoplasms
Intervention: Behavioral: Active measures of lifestyle modification
19 Recruiting Brentuximab Vedotin in Relapsed/Refractory Germ Cell Tumors
Condition: Neoplasms, Embryonal Germ Cell Tumors
Intervention: Drug: Brentuximab Vedotin
20 Recruiting Institut Paoli-Calmettes Pancreatic Neoplasms Database
Condition: Pancreatic Neoplasms
Intervention: Other: Data collection

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.